New John Hopkins webinar-
We plan to broadcast a 1-hour live webinar on Wednesday, February 23, 2022, at 1:00PM EST for our study participants. The purpose of the webinar is to share our updated findings from the Observational Study with you and answer some of your questions. The purpose of the webinar is not to provide medical advice regarding vaccines, COVID-19 treatments, or answer any other medical questions. If you are unable to view the live webcast, do not worry. The webcast will be recorded, and we will share a link of the recording with everyone in the research study as we have in the past.
The video hosting platform for this webinar will be on Microsoft Teams. You do not need a Teams account to log on (you may as a Guest), or you can use your personal Teams account if you already have one.
Please register here: https://teams.microsoft.com/registration/OPSkn-axO0eAP4b4rt8N7A,lFYj96kbT0idwVD3528Jmw,MAXcs6AtbEK6f5GJsSr1IQ,48uruCPpSU6p05ZUWKnhyw,aphrKncNXkyzVXDMfNQefA,zNlvMUtjjUmWPn-T0bg3lQ?mode=read&tenantId=9fa4f438-b1e6-473b-803f-86f8aedf0dec
You will receive an email with a link to click to join the webinar shortly after registering. On the day of the webinar, simply click that link to join. If you are not logged in to a Teams account, you will be prompted to enter your name. Please note that your name will be displayed for other study participants to see. If you would like to remain anonymous, please enter “anonymous” as your name.
Only the first 1,000 participants will be able to use the chat feature for the webinar. That means that if we exceed 1,000 viewers, person 1,001 and beyond will be able to watch, but not chat. This is a software limitation and out of our control.
We will answer some of our most frequently asked questions related to our research and have a panel discussion with experts from Johns Hopkins. If you would like to submit a question ahead of time, you may do so when you complete the registration form. We have received hundreds of questions in the past, and so cannot guarantee that every question will be answered, but we will do our best.
We would like to reiterate our thanks to you for participating in this study, and we look forward to seeing you and sharing our updates with you on February 23rd.
Respectfully,
Jennifer Alejo, MD
William Werbel, MD
Dorry Segev, MD PhD
Jacqueline Garonzik-Wang, MD PhD
Robin Avery, MD
Thanks for sharing.